Joey CohenMedication Adherence
David LinetskyPoint-of-Care Marketing
Stacey GandlerBrand Nourishment
Matthew DurhamOmnidynamic Marketing
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
Matt TurnerPatient Affordability
Suma Ramadas, PhDMedical Affairs
Pat PurcellMeeting Engagement
Daniel SontupeMarket Access
Paul TheisenPatient Acquisition
Bud BilanichSuccess Coach
Brenda SnowAuthentic Patient Voice
Amy GilesIncreasing Engagement
Encouraging results evaluating HS-110 in combination with Bristol-Myers Squibb’s anti-PD-1 checkpoint inhibitor, nivolumab (Opdivo®) ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email